• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行:从起源到结局。对病毒发病机制、临床表现、诊断评估和治疗的全面综述。

COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.

机构信息

Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Infez Med. 2021 Mar 1;29(1):20-36.

PMID:33664170
Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是 COVID-19 的病原体,于 2019 年 12 月在中国武汉首次出现,到 2020 年 3 月,它被宣布为大流行。COVID-19 大流行使大多数国家的医疗系统不堪重负,并导致了巨大的经济损失。SARS-CoV-2 主要通过呼吸道飞沫传播。平均潜伏期为 6.4 天,常见症状包括发热、咳嗽、呼吸困难、肌痛或乏力。虽然大多数患者病情较轻,但少数患者出现严重缺氧,需要住院治疗和机械通气。治疗主要是支持性的。然而,一些直接抗病毒药物和免疫调节治疗,如类固醇和各种细胞因子阻滞剂,在早期结果中显示出有希望的结果。然而,已经建立了有效的疫苗,这将有助于遏制大流行。

相似文献

1
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.COVID-19 大流行:从起源到结局。对病毒发病机制、临床表现、诊断评估和治疗的全面综述。
Infez Med. 2021 Mar 1;29(1):20-36.
2
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.新型冠状病毒的治疗措施:现状与未来展望综述。
Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230.
3
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.新冠病毒治疗和诊断方法的最新进展。
AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2.
4
Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.新型冠状病毒:从起源到治疗策略现状的综述。
Crit Rev Eukaryot Gene Expr. 2021;31(3):21-34. doi: 10.1615/CritRevEukaryotGeneExpr.2021038075.
5
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19).综述:新型冠状病毒(COVID-19)的流行病学、发病机制与疫苗研发前景。
Indian J Tuberc. 2021 Jan;68(1):92-98. doi: 10.1016/j.ijtb.2020.09.021. Epub 2020 Sep 28.
6
The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.《2019 冠状病毒病大流行时代:对动力学、临床症状和并发症、诊断及治疗的回顾》。
Genet Test Mol Biomarkers. 2021 Feb;25(2):85-101. doi: 10.1089/gtmb.2020.0227.
7
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.造血细胞移植和细胞治疗受者 COVID-19 管理指南。
Biol Blood Marrow Transplant. 2020 Nov;26(11):1983-1994. doi: 10.1016/j.bbmt.2020.07.027. Epub 2020 Jul 28.
8
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
9
The COVID-19 pandemic: a global health crisis.新型冠状病毒肺炎大流行:全球卫生危机。
Physiol Genomics. 2020 Nov 1;52(11):549-557. doi: 10.1152/physiolgenomics.00089.2020. Epub 2020 Sep 29.
10
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.2020 年希腊雅典国际研讨会:重症监护室中 COVID-19 的最新进展。
Anaesth Crit Care Pain Med. 2020 Dec;39(6):723-730. doi: 10.1016/j.accpm.2020.10.008. Epub 2020 Oct 22.

引用本文的文献

1
Occupational Therapy Interventions in Mental Health During Lockdown: A Scoping Review.封锁期间心理健康领域的职业治疗干预:一项范围综述
Healthcare (Basel). 2025 Aug 27;13(17):2136. doi: 10.3390/healthcare13172136.
2
COVID-19 delirium versus non-COVID-19 delirium in Iran: a computational approach.伊朗的新冠病毒疾病所致谵妄与非新冠病毒疾病所致谵妄:一种计算方法
Acute Crit Care. 2025 Aug;40(3):462-472. doi: 10.4266/acc.004944. Epub 2025 Jul 21.
3
The role of Na,K‑ATPase in lung diseases (Review).钠钾ATP酶在肺部疾病中的作用(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13665. Epub 2025 Aug 29.
4
Unveiling the hidden burden of COVID-19 in Brazil's obstetric population with severe acute respiratory syndrome: A machine learning model.利用机器学习模型揭示巴西患有严重急性呼吸综合征的产科人群中新冠病毒病的隐性负担
PLoS One. 2025 Aug 22;20(8):e0330375. doi: 10.1371/journal.pone.0330375. eCollection 2025.
5
Hyperamylasemia in COVID-19 patients: pancreatic involvement or secondary epiphenomenon?COVID-19患者的高淀粉酶血症:胰腺受累还是继发的附带现象?
Intern Emerg Med. 2025 Aug 20. doi: 10.1007/s11739-025-04087-y.
6
Lived experiences of COVID-19 survivors admitted to the respiratory intensive care unit (RICU): phenomenological study in Southern Iran.入住呼吸重症监护病房(RICU)的新冠肺炎幸存者的生活经历:伊朗南部的现象学研究
BMC Psychol. 2025 Aug 10;13(1):890. doi: 10.1186/s40359-025-03158-1.
7
Safe, Smart, and Scalable: A Prospective Multicenter Study on Low-Dose CT and CTSS for Emergency Risk Stratification in COVID-19.安全、智能且可扩展:一项关于低剂量CT和CTSS用于COVID-19紧急风险分层的前瞻性多中心研究。
J Clin Med. 2025 Jun 21;14(13):4423. doi: 10.3390/jcm14134423.
8
Causal relationship between gut microbiota and viral infectious disease: A 2-sample Mendelian randomization study.肠道微生物群与病毒感染性疾病之间的因果关系:一项双样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Jul 4;104(27):e43258. doi: 10.1097/MD.0000000000043258.
9
Effects of Different Bedside Physiotherapy Frequencies in Hospitalized COVID-19 Patients, Focusing on Mild to Moderate Cases.不同床边物理治疗频率对新冠肺炎住院患者的影响,重点关注轻至中度病例
Int J Environ Res Public Health. 2025 Jun 12;22(6):931. doi: 10.3390/ijerph22060931.
10
Identifying Key Hematological and Biochemical Indicators of Disease Severity in COVID-19 and Non-COVID-19 Patients.识别新冠病毒感染患者和非新冠病毒感染患者疾病严重程度的关键血液学和生化指标
Diagnostics (Basel). 2025 May 29;15(11):1374. doi: 10.3390/diagnostics15111374.